Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Modesto

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Journal of Clinical Gastroenterology|August 3, 2020
Inhibitors of the Janus Kinases: A New Oral Treatment Option for Ulcerative ColitisIrene Modesto
Expert Opinion on Biological Therapy|March 22, 2006
Infliximab and ulcerative colitisMario Cottone, Filippo Mocciaro, Irene Modesto
Current Opinion in Gastroenterology|June 9, 2006
Postoperative maintenance therapy for inflammatory bowel diseaseMario Cottone, Ambrogio Orlando, Irene Modesto
Expert Opinion on Pharmacotherapy|June 18, 2013
Mesalazine for the treatment of inflammatory bowel diseaseValeria Criscuoli, Irene Modesto, Ambrogio Orlando, et al.
Current Drug Targets|April 7, 2011
Is 5-ASA still the treatment of choice for ulcerative colitis?Mario Cottone, Sara Renna, Irene Modesto, et al.
World Journal of Gastroenterology|August 10, 2012
Methodology for high-quality studies on course and prognosis of inflammatory bowel diseaseIrene Modesto, Giovanni Perricone, Ambrogio Orlando, et al.
Inflammatory Bowel Diseases|October 3, 2006
Leukocytapheresis in patients with moderate-severe steroid-dependant ulcerative colitis: clinical response without endoscopic responseIrene Modesto, Daniela Scimeca, Ambrogio Orlando, et al.
Advances in Therapy|March 17, 2020
Comment on: "Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases"John Woolcott, Joseph C Cappelleri, Puza Sharma, et al.
Annals of the Rheumatic Diseases|March 17, 2023
Identification of two tofacitinib subpopulations with different relative risk versus TNF inhibitors: an analysis of the open label, randomised controlled study ORAL SurveillanceLars Erik Kristensen, Silvio Danese, Arne Yndestad, et al.
Journal of Crohn'S & Colitis|November 22, 2024
Low Incidence of Macular Edema and Other Ocular Events in the Etrasimod Development ProgramMarla C Dubinsky, Joseph Wu, Aoibhinn McDonnell, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Journal of Clinical Gastroenterology|August 3, 2020
Inhibitors of the Janus Kinases: A New Oral Treatment Option for Ulcerative ColitisIrene Modesto
Expert Opinion on Biological Therapy|March 22, 2006
Infliximab and ulcerative colitisMario Cottone, Filippo Mocciaro, Irene Modesto
Current Opinion in Gastroenterology|June 9, 2006
Postoperative maintenance therapy for inflammatory bowel diseaseMario Cottone, Ambrogio Orlando, Irene Modesto
Expert Opinion on Pharmacotherapy|June 18, 2013
Mesalazine for the treatment of inflammatory bowel diseaseValeria Criscuoli, Irene Modesto, Ambrogio Orlando, et al.
Current Drug Targets|April 7, 2011
Is 5-ASA still the treatment of choice for ulcerative colitis?Mario Cottone, Sara Renna, Irene Modesto, et al.
World Journal of Gastroenterology|August 10, 2012
Methodology for high-quality studies on course and prognosis of inflammatory bowel diseaseIrene Modesto, Giovanni Perricone, Ambrogio Orlando, et al.
Inflammatory Bowel Diseases|October 3, 2006
Leukocytapheresis in patients with moderate-severe steroid-dependant ulcerative colitis: clinical response without endoscopic responseIrene Modesto, Daniela Scimeca, Ambrogio Orlando, et al.
Advances in Therapy|March 17, 2020
Comment on: "Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases"John Woolcott, Joseph C Cappelleri, Puza Sharma, et al.
Annals of the Rheumatic Diseases|March 17, 2023
Identification of two tofacitinib subpopulations with different relative risk versus TNF inhibitors: an analysis of the open label, randomised controlled study ORAL SurveillanceLars Erik Kristensen, Silvio Danese, Arne Yndestad, et al.
Journal of Crohn'S & Colitis|November 22, 2024
Low Incidence of Macular Edema and Other Ocular Events in the Etrasimod Development ProgramMarla C Dubinsky, Joseph Wu, Aoibhinn McDonnell, et al.
Pageof 5